Navigation Links
CryoLife 2012 Annual Revenues Grew to a Record $131.7 Million
Date:2/14/2013

1211,643Interest expense2026179142Interest income(2)(1)(6)(14)Other than temporary investment

 impairment----340--Other (income) expense, net(55)614749Income before income taxes2,2422,86312,05211,466Income tax expense1599974,1064,095Net income$2,083$1,866$7,946$7,371Income per common share:Basic$0.08$0.07$0.29$0.26Diluted$0.07$0.07$0.28$0.26Dividends declared per share$0.025$--$0.050$--Weighted-average common shares outstanding:Basic26,82027,46926,96727,441Diluted27,35727,74527,41127,759 CRYOLIFE, INC. AND SUBSIDIARIESFinancial Highlights(In thousands)Three Months EndedTwelve Months EndedDecember 31,December 31,2012201120122011(Unaudited)(Audited)Preservation Services:Cardiac tissue

$

7,094$

6,629$

29,756$

26,618Vascular tissue8,1388,14633,84733,175Total preservation services15,23214,77563,60359,793Products:BioGlue and BioFoam13,35312,51953,21149,455PerClot1,0099173,0782,528HemoStase--(96)--1,699Revascularization technologies1,9852,4158,0925,705HeRO Graft1,106--3,115--Total products17,45315,45567,49659,387Other115167619446Total revenues$32,800$30,397$131,718$119,626Revenues:U.S.

$

25,771$

24,475$

103,804$

95,975International7,0295,92227,91423,651Total revenues$32,800$30,397$131,718$119,626 December 31,December 31,20122011(Audited)(Audited)Cash, cash equivalents, and restricted cash and securities

$

18,332$

27,017Total current assets77,50383,870Total assets157,156147,864Total current liabilities21,43021,457Total liabilities29,04426,326Shareholders' equity128,112121,538 CRYOLIFE, INC. AND SUBSIDIARIESUnaudited Reconciliation ofNon-GAAP Adjusted Net Income and Adjusted Income per Common Share – Diluted(In thousands, except per share data)Three Months EndedTwelve Months EndedDecember 31,December 31,2012201120122011GAAP:Income before income taxes$2,242$2,863$12,052$11,466Income tax expense1599974,1064,095Net in
'/>"/>

SOURCE CryoLife, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
2. CryoLife Completes Acquisition of Hemosphere
3. CryoLife to Participate in 3rd Annual Benchmark Company, LLC One-on-One Investor Conference
4. CryoLife Announces Release Date and Teleconference Call Details for 2012 Second Quarter Financial Results
5. CryoLife Reports 13% Revenue Growth for Second Quarter 2012
6. CryoLife Announces Initiation of Quarterly Cash Dividend
7. CryoLife Reports 13% Revenue Growth for Third Quarter 2012
8. CryoLife to Participate in Lazard Capital Markets 9th Annual Healthcare Conference
9. CryoLife Receives Expanded Indication for BioFoam in Europe
10. CryoLife Announces Release Date and Teleconference Call Details for 2012 Fourth Quarter and Year End Financial Results
11. CryoLife Announces Quarterly Cash Dividend for the First Quarter 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... March 31, 2015 RnRMarketResearch.com ... market research report of 68 pages with latest ... intelligence library. The report "Pemphigus - Pipeline Review, ... therapeutic development for Pemphigus , complete with ... drug target, mechanism of action (MoA), route of ...
(Date:3/31/2015)... TRIANGLE PARK, N.C. , March 31, 2015  Dr. ... International, will be attending the World Orphan Drug Congress in ... India,s regulatory approval process and orphan drugs below: ... Board (DTAB) has recommended to the Ministry of Health that ... well-regulated country, marketing authorization can be obtained in ...
(Date:3/31/2015)... Ga. , March 31, 2015   Halyard ... Care, today announced it was awarded a new purchasing ... of face masks. Effective March 1, 2015, Halyard,s standard ... with SO SOFT* lining, will be available to HealthTrust ... well as 15,000 ambulatory surgery centers, physician practices and ...
Breaking Medicine Technology:Pemphigus Therapeutic Development and Pipeline Review H1 2015 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 4Max Neeman to Discuss India's Orphan Drug Regulations at WOD 2015 2Halyard Health Signs First GPO Contracts As Independent Company 2Halyard Health Signs First GPO Contracts As Independent Company 3
(Date:4/1/2015)... Results are in for the fifth annual ... new homes from across the state exemplifying high-efficiency design. ... building techniques and new technology intended to lower energy ... (SWA) provided sustainability consulting services for 4 of the ... first- and third-place winners. , The Benker Residence, a ...
(Date:4/1/2015)... Jacksonville, Florida (PRWEB) April 01, 2015 ... eighth-annual MSPmentor 501 Global Edition, a distinguished list ... service providers (MSPs). The complete 501 list is ... ,     The top ranked MSPs in ... Europe, Middle East and Africa ,     The ...
(Date:3/31/2015)... Battle Creek, Michigan (PRWEB) March 31, 2015 ... interview retired NFL All-Pro Lawrence Taylor to discuss the problem ... treatment. Taylor, through his own history of drug abuse and ... rehabilitation process. , Nicknamed “L.T.” by his teammates on the ... by the league due to failed drug tests, yet he ...
(Date:3/31/2015)... Dr. Parsa Mohebi, founder of Parsa Mohebi Hair Restoration has been ... using beard hair to fill in balding areas on ... now become an absolute option for giving patients the best results ... that beard to scalp hair transplant can be a patients best ... dense as we would like it,” says Dr. Parsa Mohebi. , ...
(Date:3/31/2015)... Karen A. Daley, Ph.D. will address ... University’s Commencement ceremony on May 9, 2015 and ... recognition of her eminent career as a nurse, public ... caregiver and senior staff nurse at Brigham and Women’s ... leadership roles, including President of the American Nurses Association ...
Breaking Medicine News(10 mins):Health News:Steven Winter Associates’ Projects Receive Top Honors in CT Zero Energy Challenge 2Health News:Steven Winter Associates’ Projects Receive Top Honors in CT Zero Energy Challenge 3Health News:Steven Winter Associates’ Projects Receive Top Honors in CT Zero Energy Challenge 4Health News:Penton Technology Names Enterprise Integration to the MSPmentor 501 Global Edition 2Health News:Penton Technology Names Enterprise Integration to the MSPmentor 501 Global Edition 3Health News:Lawrence Taylor & Per Wickstrom Discuss the Drug Rehabilitation & Recovery Process 2Health News:Is Beard to Scalp Hair Transplant the Future? 2Health News:Rivier University to recognize nurse leader, educator and safety advocate at 80th Commencement on May 9th 2Health News:Rivier University to recognize nurse leader, educator and safety advocate at 80th Commencement on May 9th 3
... from Alcon and Initial Payments from New Galderma ... Calif., May 18 NovaBay Pharmaceuticals, Inc. (NYSE ... company developing first-in-class anti-infective products for the treatment ... without causing resistance, reported today its financial results ...
... Health, Travisa Alliance to Improve Total Care for ... commitment to provide clients with a streamlined continuum ... ), the nation,s largest provider of travel medical ... the nation,s leading expeditor of Passports and Visas: ...
... Medical Bill and Payment Support Insurance Industry Corporate ... Mitchell International, Inc., a leading provider of medical ... support tools to over 70% of U.S. automotive ... of eBill Processing and Gateway Services to Workers, ...
... May 18 /PRNewswire-FirstCall/ -- Takeda ... (Nasdaq: IDMI ) today announced that Takeda ... America), and IDM Pharma have entered into an agreement ... has established Jade Subsidiary Corporation as a wholly-owned subsidiary ...
... learn more about public health opportunities before they enroll in school. ... ... the publication of a new public health resource center that gives students ... right decisions for their education and careers. The new resource center is ...
... $1 Million Raised at Annual Nordstrom Beat the Bridge ... May 17, over 9,000 runners, walkers and all manner ... gathered at University of Washington,s Husky Stadium to participate ... Beat Diabetes event to benefit the Northwest Chapter of ...
Cached Medicine News:Health News:NovaBay Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 2Health News:NovaBay Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 3Health News:NovaBay Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 4Health News:NovaBay Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 5Health News:NovaBay Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 6Health News:NovaBay Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 7Health News:NovaBay Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 8Health News:NovaBay Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results 9Health News:Just in Time for Travel Season, Specialty Travel Companies Cement Partnership 2Health News:Mitchell and Jopari Say 'Green Transaction Initiatives' Play Key Role in P&C and Group Health Industry Environmental Best Practices 2Health News:Mitchell and Jopari Say 'Green Transaction Initiatives' Play Key Role in P&C and Group Health Industry Environmental Best Practices 3Health News:Mitchell and Jopari Say 'Green Transaction Initiatives' Play Key Role in P&C and Group Health Industry Environmental Best Practices 4Health News:Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise 2Health News:Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise 3Health News:Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise 4Health News:Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise 5Health News:Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise 6Health News:All Allied Health Schools Provides Public Health Students with Career and Education Resources 2Health News:All Allied Health Schools Provides Public Health Students with Career and Education Resources 3Health News:Seattle Laces Up to Beat the Bridge and Diabetes 2Health News:Seattle Laces Up to Beat the Bridge and Diabetes 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: